Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 21   

Articles published

ENZN 1.27 +0.02 (1.60%)
price chart
Hot Stock List: Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Corium ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) on June 25 received a letter from the Listing Qualifications staff of The NASDAQ Stock Market indicating that the Nasdaq Staff has determined that for the last 10 consecutive business days, from June 10 to June ...
Stocks in Focus : Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Citigroup Inc ...
On June 10, 2014, Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) received a letter (the �Notice�) from the Listing Qualifications staff of The NASDAQ Stock Market LLC (�Nasdaq�) indicating that, based upon the closing bid price of the Company's common ...
Related articles »  
Investors Are Watching : Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Applied ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) on 8 August announced Royalty revenues from sales of PegIntron by Merck accounted for approximately 85% and 91% of our total royalty revenues for the three months ended June 30, 2014 and 2013, ...
Today's Hot List: Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Athersys ...  Crazy Joys
Related articles »  
Traders Are Watching : Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Celgene ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) in last trading activity decreased -3.48% to close at $1.11. Company weekly performance is 3.74% while its quarterly performance stands at 27.59%.
Related articles »  
Today's Watch List : Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), GoPro ...
On June 25, 2014, Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) received a letter from the Listing Qualifications staff of The NASDAQ Stock Market LLC (�Nasdaq�) indicating that the Nasdaq Staff has determined that for the last 10 consecutive business days ...
Today's Watch List: Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Google Inc ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) on 8 august announced Most of royalty revenues are derived from sales of PegIntron.
Stocks in Focus: Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), DSP Group Inc ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) stock was upgraded by investment analysts at TheStreet from a �sell� rating to a �hold� rating in a note issued to investors on July 8. Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) in last trading activity fell -0 ...
Worth Watching Stocks : Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Sprint ...
On Friday Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) share price closed at $1.15. Company net profit margin stands at 73.00% whereas its return on equity (ROE) is 183.70%.
Watch List - Enzon Pharmaceuticals, (NASDAQ:ENZN), Forest Oil Corporation ...
Enzon Pharmaceuticals Inc (NASDAQ:ENZN)managed to keep its gain at 5.45% on above-average volume of 542,314.00 shares. The stock settled at $1.6 after floating in a range of $1.10 to $1.19.
Related articles »  
Top Stories: Amkor Technology (NASDAQ:AMKR), JD.com (NASDAQ:JD ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) on 8 August announced Royalty revenues from sales of PegIntron by Merck accounted for approximately 85% and 91% of total royalty revenues for the three months ended June 30, 2014 and 2013, respectively, ...